Amgen's most recent trend suggests a bearish bias. One trading opportunity on Amgen is a Bear Call Spread using a strike $155.00 short call and a strike $160.00 long call offers a potential 47.49% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $155.00 by expiration. The full premium credit of $1.61 would be kept by the premium seller. The risk of $3.39 would be incurred if the stock rose above the $160.00 long call strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Amgen is bearish.
The RSI indicator is at 31.93 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
AstraZeneca reboots psoriasis drug in development deal with Valeant
Tue, 01 Sep 2015 08:34:02 GMT
Valeant Strikes Psoriasis-Drug Pact With AstraZeneca
Tue, 01 Sep 2015 07:41:08 GMT
A Word of Advice for Amgen: Objects in the Mirror Are Closer Than They Appear
Mon, 31 Aug 2015 21:02:00 GMT
Cholesterol-fighting ‘game changer': Alnylam CEO
Mon, 31 Aug 2015 10:49:00 GMT
Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Sun, 30 Aug 2015 12:30:26 GMT
Also on Market Tamer…
Follow Us on Facebook